-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on Corteva, Raises Price Target to $95

Benzinga·05/28/2026 11:25:16
Listen to the news
Morgan Stanley analyst Vincent Andrews maintains Corteva (NYSE:CTVA) with a Overweight and raises the price target from $84 to $95.